IBDEI0D0 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6216,1,2,0)
 ;;=2^J1940
 ;;^UTILITY(U,$J,358.3,6216,1,3,0)
 ;;=3^Lasix per 20mg
 ;;^UTILITY(U,$J,358.3,6217,0)
 ;;=J0150^^53^540^3^^^^1
 ;;^UTILITY(U,$J,358.3,6217,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6217,1,2,0)
 ;;=2^J0150
 ;;^UTILITY(U,$J,358.3,6217,1,3,0)
 ;;=3^Adenosine 6mg
 ;;^UTILITY(U,$J,358.3,6218,0)
 ;;=J0515^^53^540^10^^^^1
 ;;^UTILITY(U,$J,358.3,6218,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6218,1,2,0)
 ;;=2^J0515
 ;;^UTILITY(U,$J,358.3,6218,1,3,0)
 ;;=3^Benzotropine per 1mg
 ;;^UTILITY(U,$J,358.3,6219,0)
 ;;=J1630^^53^540^19^^^^1
 ;;^UTILITY(U,$J,358.3,6219,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6219,1,2,0)
 ;;=2^J1630
 ;;^UTILITY(U,$J,358.3,6219,1,3,0)
 ;;=3^Haldol 5mg
 ;;^UTILITY(U,$J,358.3,6220,0)
 ;;=J1720^^53^540^20^^^^1
 ;;^UTILITY(U,$J,358.3,6220,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6220,1,2,0)
 ;;=2^J1720
 ;;^UTILITY(U,$J,358.3,6220,1,3,0)
 ;;=3^Hydrocortisone Sodium Succinate per 100mg
 ;;^UTILITY(U,$J,358.3,6221,0)
 ;;=J0780^^53^540^14^^^^1
 ;;^UTILITY(U,$J,358.3,6221,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6221,1,2,0)
 ;;=2^J0780
 ;;^UTILITY(U,$J,358.3,6221,1,3,0)
 ;;=3^Compazine 10mg
 ;;^UTILITY(U,$J,358.3,6222,0)
 ;;=J2930^^53^540^38^^^^1
 ;;^UTILITY(U,$J,358.3,6222,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6222,1,2,0)
 ;;=2^J2930
 ;;^UTILITY(U,$J,358.3,6222,1,3,0)
 ;;=3^Solu-Medrol 125mg
 ;;^UTILITY(U,$J,358.3,6223,0)
 ;;=96402^^53^540^25^^^^1
 ;;^UTILITY(U,$J,358.3,6223,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6223,1,2,0)
 ;;=2^96402
 ;;^UTILITY(U,$J,358.3,6223,1,3,0)
 ;;=3^Injec,IM,anti-neplastic hormone
 ;;^UTILITY(U,$J,358.3,6224,0)
 ;;=96372^^53^540^42^^^^1
 ;;^UTILITY(U,$J,358.3,6224,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6224,1,2,0)
 ;;=2^96372
 ;;^UTILITY(U,$J,358.3,6224,1,3,0)
 ;;=3^Ther/Proph/Diag Inj,SC/IM
 ;;^UTILITY(U,$J,358.3,6225,0)
 ;;=96373^^53^540^40^^^^1
 ;;^UTILITY(U,$J,358.3,6225,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6225,1,2,0)
 ;;=2^96373
 ;;^UTILITY(U,$J,358.3,6225,1,3,0)
 ;;=3^Ther/Proph/Diag Inj, IA
 ;;^UTILITY(U,$J,358.3,6226,0)
 ;;=96374^^53^540^41^^^^1
 ;;^UTILITY(U,$J,358.3,6226,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6226,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,6226,1,3,0)
 ;;=3^Ther/Proph/Diag Inj, IV Push
 ;;^UTILITY(U,$J,358.3,6227,0)
 ;;=96401^^53^540^24^^^^1
 ;;^UTILITY(U,$J,358.3,6227,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6227,1,2,0)
 ;;=2^96401
 ;;^UTILITY(U,$J,358.3,6227,1,3,0)
 ;;=3^Inj IM,Anti-Neplastic Non-Hormonal
 ;;^UTILITY(U,$J,358.3,6228,0)
 ;;=J3030^^53^540^23^^^^1
 ;;^UTILITY(U,$J,358.3,6228,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6228,1,2,0)
 ;;=2^J3030
 ;;^UTILITY(U,$J,358.3,6228,1,3,0)
 ;;=3^Imitrex 6mg
 ;;^UTILITY(U,$J,358.3,6229,0)
 ;;=J2550^^53^540^36^^^^1
 ;;^UTILITY(U,$J,358.3,6229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6229,1,2,0)
 ;;=2^J2550
 ;;^UTILITY(U,$J,358.3,6229,1,3,0)
 ;;=3^Phenergan up to 50mg
 ;;^UTILITY(U,$J,358.3,6230,0)
 ;;=J0461^^53^540^8^^^^1
 ;;^UTILITY(U,$J,358.3,6230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6230,1,2,0)
 ;;=2^J0461
 ;;^UTILITY(U,$J,358.3,6230,1,3,0)
 ;;=3^Atropine Sulfate 0.01mg
 ;;^UTILITY(U,$J,358.3,6231,0)
 ;;=96360^^53^540^17^^^^1
 ;;^UTILITY(U,$J,358.3,6231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6231,1,2,0)
 ;;=2^96360
 ;;^UTILITY(U,$J,358.3,6231,1,3,0)
 ;;=3^HYDRATION,IV,1ST HR
 ;;^UTILITY(U,$J,358.3,6232,0)
 ;;=96361^^53^540^18^^^^1
 ;;^UTILITY(U,$J,358.3,6232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6232,1,2,0)
 ;;=2^96361
 ;;^UTILITY(U,$J,358.3,6232,1,3,0)
 ;;=3^HYDRATION,IV,EA ADDL HR
